Presentation: Mendelian randomization using biological foundation models improves discovery power over additive QTLs and prioritizes cell-type specific therapeutic targets
Location: Montreal, QC
Date: October 20-24, 2026
Presenters: Chris Cole, Lead Scientist at Deep Genomics, Noah Lorincz-Comi, Research Scientist, Statistical Genetics, Deep Genomics